Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Fluoxetine
Cat. No.:
0225LY-0537
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Fluoxetine is a highly selective 5-HT reuptake inhibitor utilized primarily for its antidepressant pharmacological activity.
Synonym:
LY-110140; 54910-89-3
CAS No.:
54910-89-3
Formula:
C17H18F3NO
Formula Weight:
309.33
Specification
Relative Density:
1.159 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Fluoxetine can be used in behavioral neuroscience to investigate the selective inhibition of serotonin reuptake in the central nervous system.
Library Information
Target:
MRP; 5-HT receptor; Serotonin transporter
Receptor:
MRP1; 5-HT receptor; SERT
Pathways:
Immunology/Inflammation; GPCR/G protein signaling; Autophagy; Neuronal signaling
Plate Number:
AOCL-7
Plate Location:
h11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
237.5 mg/mL; 767.79 mM
